Oracle has increased its focus on healthcare by unveiling the development of a generative AI platform to tackle data fragmentation. They have hope that this development will speed up the process of putting relevant information to use in the health and life sciences.
The Oracle Life Sciences AI Data Platform targets companies and organisations in the pharmaceutical, medical device, research and life sciences sectors.
It is intended to combine and automate large and diverse datasets to cut the time taken to interpret information and uncover other usable details.
Seema Verma, EVP and General Manager at Oracle Health and Life Sciences, said unreliable data “is a major barrier to progress” in developing “the medical breakthroughs that could transform and even save lives”.
Oracle stated the platform accesses customer and third-party data, and more than 129 million anonymised health records from a related database.
It uses AI agents which can be tailored to specific tasks, all with the goal of enabling organisations to conduct a range of healthcare and monitoring functions.
Source: Mobile World Live
Image Credit: Oracle
